A gene therapy for neovascular age-related macular degeneration in the second eye shows safety and preservation of vision and anatomy a year after the first eye was treated. Medscape Medical News
A gene therapy for neovascular age-related macular degeneration in the second eye shows safety and preservation of vision and anatomy a year after the first eye was treated. Medscape Medical News